CAPSONI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 7.395
EU - Europa 7.087
AS - Asia 880
Continente sconosciuto - Info sul continente non disponibili 49
AF - Africa 7
SA - Sud America 6
OC - Oceania 3
Totale 15.427
Nazione #
US - Stati Uniti d'America 7.363
IT - Italia 1.946
SE - Svezia 1.598
IE - Irlanda 1.247
UA - Ucraina 601
DE - Germania 595
TR - Turchia 531
GB - Regno Unito 348
FI - Finlandia 212
CN - Cina 189
RU - Federazione Russa 149
CH - Svizzera 128
AT - Austria 85
IL - Israele 54
BE - Belgio 49
EU - Europa 47
VN - Vietnam 39
CA - Canada 32
FR - Francia 32
AL - Albania 22
JP - Giappone 17
NL - Olanda 15
KR - Corea 10
SG - Singapore 10
IN - India 8
DK - Danimarca 7
ES - Italia 7
HU - Ungheria 6
RS - Serbia 6
PL - Polonia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
LU - Lussemburgo 4
EG - Egitto 3
IR - Iran 3
PT - Portogallo 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BR - Brasile 2
CL - Cile 2
GR - Grecia 2
IM - Isola di Man 2
LI - Liechtenstein 2
MD - Moldavia 2
MT - Malta 2
PH - Filippine 2
PK - Pakistan 2
RO - Romania 2
TW - Taiwan 2
ZA - Sudafrica 2
AR - Argentina 1
BN - Brunei Darussalam 1
HK - Hong Kong 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 15.427
Città #
Chandler 1.373
Pisa 1.302
Jacksonville 1.300
Dublin 1.245
Izmir 529
Wilmington 526
Ashburn 504
Ann Arbor 399
Boston 280
Millbury 264
Boardman 226
Düsseldorf 220
Mestre 188
San Mateo 181
New York 156
Ogden 121
Bremen 119
Seattle 109
Bern 107
Princeton 106
Washington 93
Lawrence 91
Woodbridge 88
Vienna 79
San Paolo di Civitate 67
Saint Petersburg 63
Dearborn 53
Holon 51
Beijing 49
Brussels 45
Milan 41
Dong Ket 39
Helsinki 38
Scuola 38
San Giuliano Terme 28
Fairfield 26
Hefei 24
Rome 24
Norwalk 23
Toronto 22
Chicago 21
Houston 19
Las Vegas 19
Nanjing 19
Bientina 15
Edinburgh 15
Andover 14
Kunming 14
Los Angeles 14
Tokyo 14
Berlin 13
Padova 12
San Diego 11
Cambridge 10
Lausanne 10
Falls Church 9
Guangzhou 9
Jinan 9
Paris 9
Zurich 9
Florence 8
London 8
Tappahannock 8
Voghera 8
Auburn Hills 7
Seoul 7
Stockholm 7
Verona 7
Budapest 6
Cusano Milanino 6
Graz 6
Nanchang 6
Singapore 6
Trieste 6
Amsterdam 5
Centrale 5
Livorno 5
Redmond 5
Shenyang 5
Chantilly 4
Chengdu 4
Council Bluffs 4
Hanover 4
Lappeenranta 4
Leawood 4
Luxembourg 4
Prague 4
Sofia 4
Wuhan 4
Belgrade 3
Copenhagen 3
Cormeilles-en-Parisis 3
Fuzhou 3
Gorizia 3
Hebei 3
Laurel 3
Novi Sad 3
Quzhou 3
Trumbull 3
Vancouver 3
Totale 10.696
Nome #
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 154
(2008) Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-ß-Mediated Cortical Synaptic Dysfunction 153
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 137
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 136
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 130
null 129
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 129
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 123
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 123
NGF steers microglia toward a neuroprotective phenotype 123
Enteric Alpha-synuclein inclusions, colonic inflammation, increased mucosal permeability and alterations of Bowel neuromuscular functiond precede central neurodegeneration in a transgenic mouse model of Parkinson's disease 119
The contribution of early inflammation to neurodegeneration in anti-Nerve Growth Factor mice 118
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 116
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 112
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 112
Role of NGF in modulating adult neurogenesis in ALzheimer's disease mouse model 110
Graphene promotes axon elongation through local stall of Nerve Growth Factor signaling endosomes 109
Nerve Growth Factor regulates astrocyte physiology in vivo 108
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 108
The role of Nerve Growth Factor in development and in ALzheimer's disease 107
Morphological basis for pineal secretion in domestic Ungulata 107
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. 107
Enteric alpha-synuclein accumulation impairs intestinal epithelial barrier through inflammasome activation before the onset of brain pathology in a transgenic mouse model of Parkinson's disease 107
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 106
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 105
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 104
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 103
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 102
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 102
Pathogen Free Conditions Slow the Onset of Neurodegeneration in a Mouse Model of Nerve Growth Factor Deprivation 101
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 101
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 100
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 99
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 99
Involvement of NGF in early stages of chick embryo development 99
Effects of cholinesterase inhibitor galantamine in a mouse model of Alzheimer disease, the anti-NGF AD11 mice 99
A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 98
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 98
Cholinesterase inhibitors with nicotinic mode of action: Neuroprotection in anti-NGF mice 98
Role of NGF in modulating adult neurogenesis in an Alzheimer's disease mouse model 98
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 97
Inflammatory responses in anti-Nerve Growth Factor transgenic mice 97
A new generation of NGF-based therapy for Alzheimer’s disease 97
Neutralization of nerve growth factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 97
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 97
Autoradiographic quantification of endothelin ET(A)receptors in peripheral and brain arteries of the rat 96
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 95
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 95
Environmental enrichment prevents the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 94
Expression of the melatonin receptors in Xenopus laevis 94
Abeta (1-42) impairs LTP in mous eneocortex through RAGE mediated activation of p38 MAP kinase 93
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 92
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 92
Alzheimer-like neurodegeneration in aged anti-Nerve Growth Factor (NGF) mice 92
A new generation of non invasive NGF-based therapies for Alzheimer’s Disease 91
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 91
IN VITRO RECEPTOR BINDING PROPERTIES OF A "PAINLESS" NGF MUTEIN, LINKED TO HEREDITARY SENSORY AUTONOMIC NEUROPATHY TYPE V 91
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 91
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity. 91
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 90
Interfering with the intracellular trafficking of Aß Oligomers with conformational intrabodies 90
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 90
Long-term memantine treatment prevents behaviour deficits in a mouse model of sporadic Alzheimer's disease 89
Alzheimer-like neurodegeneration in anti-Nerve Growth Factor transgenic mice 89
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice 89
Rage deficiency rescues Aß-mediated inhibitory effects of different forms of long-term potentiation in mouse neocortex 88
Intranasal "painless" Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice 88
Nerve Growth Factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 87
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 87
Transgenic mouse models of neurotrophin function and effects on amyloid plaques and neurofibrillary pathology 87
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 86
Development of human Nerve Growth Factor muteins with reduced algesic properties 86
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 86
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 86
An unbalance of proNGF/NGF signalling determines AD-like neurodegeneration in mice. 86
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 86
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 85
Memoquin, a novel multifunctional compound for Alzheimer’s disease: an up-date on preclinical studies 85
Design and characterization of human Nerve Growth Factor muteins with reduced algesic properties and their application to drug discovery in Alzheimer’s disease 84
Phenotypic characterization of mice expressing anti-TrkA antibodies 84
Memoquin, a new compound to attack Alzheimer's disease: preclinical studies 84
Melatonin receptors in brain and peripheral arteries 83
Memoquin: a new compound to attack Alzheimer disease on multiple fronts 83
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 82
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 82
Rat visual cortical neurones express TrkA NGF receptor 82
The effects of knocking out of p75NTR on the neurodegenerative phenotype in AD11 anti-NGF mice 82
ProNGF Drives Localized and Cell Selective Parvalbumin Interneuron and Perineuronal Net Depletion in the Dentate Gyrus of Transgenic Mice 82
Non-human transgenic animals for the study of neurodegenerative syndromes 81
Effects of combination treatment of galantamine and memantine on AD11 anti-NGF mice 81
PHENOTYPIC KNOCKOUT OF NERVE GROWTH FACTOR IN ADULT TRANSGENIC MICE REVEALS SEVERE DEFICITS IN BASAL FOREBRAIN CHOLINERGIC NEURONS, CELL DEATH IN THE SPLEEN, AND SKELETAL MUSCLE DYSTROPHY 81
Synaptic plasticity impairment in visual cortex of adult anti-NGF mice 81
Organotypic cultures from AD11 anti-NGF transgenic mice: an in vitro model system to study neurodegeneration 81
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 81
Design and characterization of human Nerve Grwoth Factor muteins with reduced algesic properties and their application to drug discovery in Alzheimer's disease 80
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 80
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 80
Postnatal development of astrocytes in mouse visual cortex: role of the visual experience 80
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 79
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 79
Totale 9.724
Categoria #
all - tutte 60.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019543 0 0 0 0 0 0 0 0 0 0 12 531
2019/20201.473 246 169 24 13 186 52 300 53 191 32 195 12
2020/20212.437 195 17 501 16 185 216 76 197 209 421 128 276
2021/20221.470 141 14 11 78 99 19 31 127 92 76 71 711
2022/20236.174 413 377 260 427 382 599 4 1.562 1.850 33 124 143
2023/20241.570 268 47 215 47 137 388 72 106 209 72 9 0
Totale 15.693